Proteome Sciences plc (LON:PRM – Get Free Report) shares were up 22.4% during mid-day trading on Wednesday . The stock traded as high as GBX 3 and last traded at GBX 2.76. Approximately 472,430 shares were traded during trading, an increase of 99% from the average daily volume of 237,921 shares. The stock had previously closed at GBX 2.26.
Proteome Sciences Stock Performance
The business’s fifty day moving average price is GBX 2.01 and its 200-day moving average price is GBX 2.55. The stock has a market cap of £7.38 million, a PE ratio of -2.21 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
See Also
- Five stocks we like better than Proteome Sciences
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Trump’s new AI budget just passed — one stock could soar
- $4,200 gold is nice … but here’s what most gold bugs are missing
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
